Accessibility Statement Skip Navigation
  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing
  • Login
  • GDPR
  • Create a Free Account
Return to PRWeb homepage
  • News
  • Resources
  • Contact
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News in Focus
      • Browse News Releases

      • All News Releases
      • Multimedia Gallery

      • All Multimedia
      • All Photos
      • All Videos
  • Business & Money
      • Auto & Transportation

      • Aerospace, Defense
      • Air Freight
      • Airlines & Aviation
      • Automotive
      • Maritime & Shipbuilding
      • Railroads and Intermodal Transportation
      • Supply Chain/Logistics
      • Transportation, Trucking & Railroad
      • Travel
      • Trucking and Road Transportation
      • View All Auto & Transportation

      • Business Technology

      • Blockchain
      • Broadcast Tech
      • Computer & Electronics
      • Computer Hardware
      • Computer Software
      • Data Analytics
      • Electronic Commerce
      • Electronic Components
      • Electronic Design Automation
      • Financial Technology
      • High Tech Security
      • Internet Technology
      • Nanotechnology
      • Networks
      • Peripherals
      • Semiconductors
      • View All Business Technology

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Financial Services & Investing

      • Accounting News & Issues
      • Acquisitions, Mergers and Takeovers
      • Banking & Financial Services
      • Bankruptcy
      • Bond & Stock Ratings
      • Conference Call Announcements
      • Contracts
      • Cryptocurrency
      • Dividends
      • Earnings
      • Earnings Forecasts & Projections
      • Financing Agreements
      • Insurance
      • Investments Opinions
      • Joint Ventures
      • Mutual Funds
      • Private Placement
      • Real Estate
      • Restructuring & Recapitalization
      • Sales Reports
      • Shareholder Activism
      • Shareholder Meetings
      • Stock Offering
      • Stock Split
      • Venture Capital
      • View All Financial Services & Investing

      • General Business

      • Awards
      • Commercial Real Estate
      • Corporate Expansion
      • Earnings
      • Environmental, Social and Governance (ESG)
      • Human Resource & Workforce Management
      • Licensing
      • New Products & Services
      • Obituaries
      • Outsourcing Businesses
      • Overseas Real Estate (non-US)
      • Personnel Announcements
      • Real Estate Transactions
      • Residential Real Estate
      • Small Business Services
      • Socially Responsible Investing
      • Surveys, Polls and Research
      • Trade Show News
      • View All General Business

  • Science & Tech
      • Consumer Technology

      • Artificial Intelligence
      • Blockchain
      • Cloud Computing/Internet of Things
      • Computer Electronics
      • Computer Hardware
      • Computer Software
      • Consumer Electronics
      • Cryptocurrency
      • Data Analytics
      • Electronic Commerce
      • Electronic Gaming
      • Financial Technology
      • Mobile Entertainment
      • Multimedia & Internet
      • Peripherals
      • Social Media
      • STEM (Science, Tech, Engineering, Math)
      • Supply Chain/Logistics
      • Wireless Communications
      • View All Consumer Technology

      • Energy & Natural Resources

      • Alternative Energies
      • Chemical
      • Electrical Utilities
      • Gas
      • General Manufacturing
      • Mining
      • Mining & Metals
      • Oil & Energy
      • Oil and Gas Discoveries
      • Utilities
      • Water Utilities
      • View All Energy & Natural Resources

      • Environ­ment

      • Conservation & Recycling
      • Environmental Issues
      • Environmental Policy
      • Environmental Products & Services
      • Green Technology
      • Natural Disasters
      • View All Environ­ment

      • Heavy Industry & Manufacturing

      • Aerospace & Defense
      • Agriculture
      • Chemical
      • Construction & Building
      • General Manufacturing
      • HVAC (Heating, Ventilation and Air-Conditioning)
      • Machinery
      • Machine Tools, Metalworking and Metallurgy
      • Mining
      • Mining & Metals
      • Paper, Forest Products & Containers
      • Precious Metals
      • Textiles
      • Tobacco
      • View All Heavy Industry & Manufacturing

      • Telecomm­unications

      • Carriers and Services
      • Mobile Entertainment
      • Networks
      • Peripherals
      • Telecommunications Equipment
      • Telecommunications Industry
      • VoIP (Voice over Internet Protocol)
      • Wireless Communications
      • View All Telecomm­unications

  • Lifestyle & Health
      • Consumer Products & Retail

      • Animals & Pets
      • Beers, Wines and Spirits
      • Beverages
      • Bridal Services
      • Cannabis
      • Cosmetics and Personal Care
      • Fashion
      • Food & Beverages
      • Furniture and Furnishings
      • Home Improvement
      • Household, Consumer & Cosmetics
      • Household Products
      • Jewelry
      • Non-Alcoholic Beverages
      • Office Products
      • Organic Food
      • Product Recalls
      • Restaurants
      • Retail
      • Supermarkets
      • Toys
      • View All Consumer Products & Retail

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Health

      • Biometrics
      • Biotechnology
      • Clinical Trials & Medical Discoveries
      • Dentistry
      • FDA Approval
      • Fitness/Wellness
      • Health Care & Hospitals
      • Health Insurance
      • Infection Control
      • International Medical Approval
      • Medical Equipment
      • Medical Pharmaceuticals
      • Mental Health
      • Pharmaceuticals
      • Supplementary Medicine
      • View All Health

      • Sports

      • General Sports
      • Outdoors, Camping & Hiking
      • Sporting Events
      • Sports Equipment & Accessories
      • View All Sports

      • Travel

      • Amusement Parks and Tourist Attractions
      • Gambling & Casinos
      • Hotels and Resorts
      • Leisure & Tourism
      • Outdoors, Camping & Hiking
      • Passenger Aviation
      • Travel Industry
      • View All Travel

  • Policy & Public Interest
      • Policy & Public Interest

      • Advocacy Group Opinion
      • Animal Welfare
      • Congressional & Presidential Campaigns
      • Corporate Social Responsibility
      • Domestic Policy
      • Economic News, Trends, Analysis
      • Education
      • Environmental
      • European Government
      • FDA Approval
      • Federal and State Legislation
      • Federal Executive Branch & Agency
      • Foreign Policy & International Affairs
      • Homeland Security
      • Labor & Union
      • Legal Issues
      • Natural Disasters
      • Not For Profit
      • Patent Law
      • Public Safety
      • Trade Policy
      • U.S. State Policy
      • View All Policy & Public Interest

  • People & Culture
      • People & Culture

      • Aboriginal, First Nations & Native American
      • African American
      • Asian American
      • Children
      • Diversity, Equity & Inclusion
      • Hispanic
      • Lesbian, Gay & Bisexual
      • Men's Interest
      • People with Disabilities
      • Religion
      • Senior Citizens
      • Veterans
      • Women
      • View All People & Culture

  • Hamburger menu
  • Cision PRWeb provides efficient communication tools to continuously engage with target audiences across multiple online channels
  • Create a Free Account
    • ALL CONTACT INFO
    • Contact Us


      11AM ET Sunday – 8PM ET Friday

  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • News in Focus
    • Browse All News
    • Multimedia Gallery
  • Business & Money
    • Auto & Transportation
    • Business Technology
    • Entertain­ment & Media
    • Financial Services & Investing
    • General Business
  • Science & Tech
    • Consumer Technology
    • Energy & Natural Resources
    • Environ­ment
    • Heavy Industry & Manufacturing
    • Telecomm­unications
  • Lifestyle & Health
    • Consumer Products & Retail
    • Entertain­ment & Media
    • Health
    • Sports
    • Travel
  • Policy & Public Interest
  • People & Culture
    • People & Culture
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR

$100,000 Awarded to Rimidi Diabetes and TruClinic for Health Business Solutions that Benefit Patients and Providers
  • USA - English


News provided by

The Hitachi Foundation

Sep 23, 2014, 13:00 ET

Share this article

Share toX

Share this article

Share toX

Solutions from Our Country’s Entrepreneurs
Solutions from Our Country’s Entrepreneurs

Boston, MA (PRWEB) September 23, 2014 -- SOURCE: Solutions from Our Country’s Entrepreneurs today announced that $50,000 investments each were made to Rimidi Diabetes and TruClinic (TM) as the top two health ventures with business solutions to challenges faced by patients and healthcare systems.

SOURCE is a first-of-its-kind collaboration between The Hitachi Foundation, Village Capital, and Investors' Circle that connects entrepreneurs with the investment capital, mentoring, and support needed to grow their businesses. Twelve ventures participated in the three-month Village Capital/VentureWell business accelerator program. The ventures focus on a diverse range of health and healthcare challenges, many impacting low-wealth Americans. The program uses a peer-driven approach where the participants use business criteria to select two of their fellow companies for funding.

Rimidi’s Diabetes+Me (TM) is a software solution focused on effectively and safely managing blood glucose, which allows patients and physicians to identify and close gaps in diabetes management. TruClinic (TM) provides a universal telemedicine platform for patients to set up secure video conferences with healthcare providers to avoid unnecessary in-person visits and their associated costs.

"We are thrilled to work with these two companies as they improve access to opportunity for underserved people worldwide through better health outcomes,” said Ross Baird, executive director of Village Capital. “Diabetes is a disease that affects more than 29 million Americans, including an estimated 12.5 million who are low-income. Rimidi helps people with diabetes live a healthy lifestyle through an engaging user experience. TruClinic expands the reach of affordable medicine to low-income people who do not have access to quality healthcare in a way that revolutionizes the way that doctors treat patients."

The announcement of the two top ventures was made after the Village Capital/VentureWell Venture Forum where the entrepreneurs presented their business plans to a group of angel investors, venture capitalists, community leaders, potential partners, and customers. Rimidi Diabetes and TruClinic were then given the opportunity to present their business plans to another group of potential investors at an Investors’ Circle Boston local network meeting.

“We heard an impressive set of pitches at the Venture Forum that demonstrated the impact these emerging innovations can and will have,” said Phil Weilerstein, president of VentureWell. “Programs like ours are possible thanks to an outstanding group of partners including Village Capital, our investor partners, business mentors, and the early stage companies and entrepreneurs who participated in this training.”

The ten other ventures that participated in the Village Capital/VentureWell program are:
• Benevolent Technologies for Health (BeTH) – Reduced cost and improved comfort of prostheses.
• Dock Technologies – Disposable, visible reminders to help nurses improve time-based quality measures.
• Doctible.com – Price shopping for health procedures.
• EyeMitra – Mobile retinal imaging platform.
• Healthy TXT – Automated follow-up messaging for patients and physicians.
• Innoblative Designs – Treating early-stage breast cancer faster with radiation-alternative.
• Kohana – Wearable compression-based breast pump for working moms.
• PEURegen – A biodegradable, synthetic skin scaffold for deep skin wounds.
• Semantic MD – Helping radiologists be more efficient and accurate via big data analytics.
• Twiage – Fast, secure, accurate information about incoming ER patients.

The Village Capital/VentureWell Health program was made possible in partnership with MIT H@cking Medicine, with program support from the Sorenson Global Impact Investing Center, The Rockefeller Foundation, The Lemelson Foundation, and Global Impact Investing Rating System.

About SOURCE
SOURCE is a partnership between The Hitachi Foundation, Investors’ Circle, and Village Capital, with additional support from The Rockefeller Foundation and the Sorenson Global Impact Investing Center. SOURCE discovers entrepreneurs creating business solutions to social issues affecting low-wealth Americans and links them with the investment capital and mentoring needed to grow their businesses.

About The Hitachi Foundation
The Hitachi Foundation is an independent, philanthropic organization that seeks to discover, demonstrate and expand business practices that both measurably improve economic opportunities for low-wealth individuals in the U.S. and enhance long term business value.

About Village Capital
Village Capital uses the power of peer support to build companies that change the world. We recruit entrepreneurs who are solving major global problems in the areas of health, energy, education, financial inclusion, and agriculture. We operate business acceleration programs with a curriculum focused on improving ventures’ ability to meet customer demand. Through a unique investment model, entrepreneurs themselves decide which innovations receive critical early-stage investment capital from Village Capital and partner investors. Village Capital teamed up with VentureWell to produce the Boston health program.

About Investors’ Circle
Investors’ Circle (IC) is the largest early-stage impact investing network in the world. Together with hundreds of angels, venture capitalists, foundations and family offices, IC has propelled over $175 million into more than 275 enterprises dedicated to improving the environment, education, health, and community. A nonprofit organization, IC cultivates its impact investor network, provides opportunities for high-potential impact entrepreneurs to meet impact investors, and facilitates investment.

About VentureWell
VentureWell was founded in 1995 as the National Collegiate Inventors and Innovators Alliance (NCIIA) and rebranded in 2014 to underscore its impact as an education network that cultivates revolutionary ideas and promising inventions. A not-for-profit organization reaching more than 200 universities, VentureWell is the leader in funding, training, coaching and early investment that brings student innovations to market. Inventions created by VentureWell grantees are reaching millions of people in more than 50 countries and helping to solve some of our greatest 21st century challenges. Visit VentureWell.org to learn how they inspire students, faculty and investors to transform game-changing ideas into solutions for people and the planet.

                                                                         ###

Laura Faulkner, The Hitachi Foundation, http://www.hitachifoundation.org/, +1 (202) 828-1654, [email protected]

Modal title

Contact PRWeb

  • 11AM ET Sunday – 8PM ET Friday
  • Contact Us

About PRWeb

  • About PRWeb
  • Partners
  • Partnership Programs
  • Editorial Guidelines
  • Resources

Why PRWeb

  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing

Accounts

  • Create a Free Account
  • Log in
  • Contact Us

Do not sell or share my personal information:

  • Submit via [email protected] 
  • Call Privacy toll-free: 877-297-8921

Contact Cision

Products

About

My Services
  • All News Releases
  • Online Member Center
  • ProfNet
Cision Distribution Helpline
888-776-0942
  • Legal
  • Site Map
  • RSS
  • Cookie Settings
Copyright © 2025 Cision US Inc.